Glenmark Life Sciences Cash Flow Annual

Trade
BSE: 543322 | NSE: GLS | ISIN: INE03Q201024 | Sector: Biotechnology & Drugs
833.90 +13.50 (1.65%)Updated : 22 May 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Net Income/ Starting Line 631.291,952.341,098.841,331.10
Depreciation/ Depletion 53.45245.65281.63227.09
Non- Cash Items 37.84437.31427.90314.60
Changesin Working Capital -309.06-2,450.89-1,641.92-2,329.62
Cashfrom Operating Activities 413.52184.41166.45-456.83
Capital Expenditures -128.97-297.48-434.64-516.41
Other Investing Cash Flow Items Total 12.49-259.25177.50-218.88
Cashfrom Investing Activities -116.48-556.73-257.14-735.29
Financing Cash Flow Items -1.55-460.26-382.35-347.59
Total Cash Dividends Paid -275.69---
Issuance( Retirement)of Debt Net -2.21439.93693.161,320.91
Cashfrom Financing Activities -279.44-20.34310.82971.94
Net Changein Cash 17.59-392.65220.12-220.18
Cash Interest Paid 1.55460.26382.35347.59
Cash Taxes Paid 162.96357.23311.97284.83
Issuance( Retirement)of Stock Net ----1.38
*All figures in crores except per share values
Recommended For You
Trending Stocks
2,366.80+56.55(2.45%)
2,920.75+49.45(1.72%)
1,454.65+20.45(1.43%)
819.30-11.25 (-1.35%)
1,127.70-9.90 (-0.87%)
HomeMarketsPremiumFor youGet App